Cargando…
Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts
OBJECTIVE: To investigate markers of premature menopause (<40 years) and specifically the prevalence of autoimmune primary ovarian insufficiency (POI) in European women. DESIGN: Postmenopausal women were categorized according to age at menopause and self-reported reason for menopause in a cross-s...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175594/ https://www.ncbi.nlm.nih.gov/pubmed/35521804 http://dx.doi.org/10.1530/EC-22-0024 |
_version_ | 1784722486447833088 |
---|---|
author | Vogt, Elinor Chelsom Real, Francisco Gómez Husebye, Eystein Sverre Björnsdottir, Sigridur Benediktsdottir, Bryndis Bertelsen, Randi Jacobsen Demoly, Pascal Franklin, Karl Anders de Aja Gallastegui, Leire Sainz González, Francisco Javier Callejas Heinrich, Joachim Holm, Mathias Jogi, Nils Oscar Leynaert, Benedicte Lindberg, Eva Malinovschi, Andrei Martínez-Moratalla, Jesús Mayoral, Raúl Godoy Oudin, Anna Pereira-Vega, Antonio Semjen, Chantal Raherison Schlünssen, Vivi Triebner, Kai Øksnes, Marianne |
author_facet | Vogt, Elinor Chelsom Real, Francisco Gómez Husebye, Eystein Sverre Björnsdottir, Sigridur Benediktsdottir, Bryndis Bertelsen, Randi Jacobsen Demoly, Pascal Franklin, Karl Anders de Aja Gallastegui, Leire Sainz González, Francisco Javier Callejas Heinrich, Joachim Holm, Mathias Jogi, Nils Oscar Leynaert, Benedicte Lindberg, Eva Malinovschi, Andrei Martínez-Moratalla, Jesús Mayoral, Raúl Godoy Oudin, Anna Pereira-Vega, Antonio Semjen, Chantal Raherison Schlünssen, Vivi Triebner, Kai Øksnes, Marianne |
author_sort | Vogt, Elinor Chelsom |
collection | PubMed |
description | OBJECTIVE: To investigate markers of premature menopause (<40 years) and specifically the prevalence of autoimmune primary ovarian insufficiency (POI) in European women. DESIGN: Postmenopausal women were categorized according to age at menopause and self-reported reason for menopause in a cross-sectional analysis of 6870 women. METHODS: Variables associated with the timing of menopause and hormone measurements of 17β-estradiol and follicle-stimulating hormone were explored using multivariable logistic regression analysis. Specific immunoprecipitating assays of steroidogenic autoantibodies against 21-hydroxylase (21-OH), side-chain cleavage enzyme (anti-SCC) and 17alpha-hydroxylase (17 OH), as well as NACHT leucine-rich-repeat protein 5 were used to identify women with likely autoimmune POI. RESULTS: Premature menopause was identified in 2.8% of women, and these women had higher frequencies of nulliparity (37.4% vs 19.7%), obesity (28.7% vs 21.4%), osteoporosis (17.1% vs 11.6%), hormone replacement therapy (59.1% vs 36.9%) and never smokers (60.1% vs 50.9%) (P < 0.05), compared to women with menopause ≥40 years. Iatrogenic causes were found in 91 (47%) and non-ovarian causes in 27 (14%) women, while 77 (39%) women were classified as POI of unknown cause, resulting in a 1.1% prevalence of idiopathic POI. After adjustments nulliparity was the only variable significantly associated with POI (odds ratio 2.46; 95% CI 1.63–3.42). Based on the presence of autoantibodies against 21 OH and SCC, 4.5% of POI cases were of likely autoimmune origin. CONCLUSION: Idiopathic POI affects 1.1% of all women and almost half of the women with premature menopause. Autoimmunity explains 4.5% of these cases judged by positive steroidogenic autoantibodies. |
format | Online Article Text |
id | pubmed-9175594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-91755942022-06-14 Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts Vogt, Elinor Chelsom Real, Francisco Gómez Husebye, Eystein Sverre Björnsdottir, Sigridur Benediktsdottir, Bryndis Bertelsen, Randi Jacobsen Demoly, Pascal Franklin, Karl Anders de Aja Gallastegui, Leire Sainz González, Francisco Javier Callejas Heinrich, Joachim Holm, Mathias Jogi, Nils Oscar Leynaert, Benedicte Lindberg, Eva Malinovschi, Andrei Martínez-Moratalla, Jesús Mayoral, Raúl Godoy Oudin, Anna Pereira-Vega, Antonio Semjen, Chantal Raherison Schlünssen, Vivi Triebner, Kai Øksnes, Marianne Endocr Connect Research OBJECTIVE: To investigate markers of premature menopause (<40 years) and specifically the prevalence of autoimmune primary ovarian insufficiency (POI) in European women. DESIGN: Postmenopausal women were categorized according to age at menopause and self-reported reason for menopause in a cross-sectional analysis of 6870 women. METHODS: Variables associated with the timing of menopause and hormone measurements of 17β-estradiol and follicle-stimulating hormone were explored using multivariable logistic regression analysis. Specific immunoprecipitating assays of steroidogenic autoantibodies against 21-hydroxylase (21-OH), side-chain cleavage enzyme (anti-SCC) and 17alpha-hydroxylase (17 OH), as well as NACHT leucine-rich-repeat protein 5 were used to identify women with likely autoimmune POI. RESULTS: Premature menopause was identified in 2.8% of women, and these women had higher frequencies of nulliparity (37.4% vs 19.7%), obesity (28.7% vs 21.4%), osteoporosis (17.1% vs 11.6%), hormone replacement therapy (59.1% vs 36.9%) and never smokers (60.1% vs 50.9%) (P < 0.05), compared to women with menopause ≥40 years. Iatrogenic causes were found in 91 (47%) and non-ovarian causes in 27 (14%) women, while 77 (39%) women were classified as POI of unknown cause, resulting in a 1.1% prevalence of idiopathic POI. After adjustments nulliparity was the only variable significantly associated with POI (odds ratio 2.46; 95% CI 1.63–3.42). Based on the presence of autoantibodies against 21 OH and SCC, 4.5% of POI cases were of likely autoimmune origin. CONCLUSION: Idiopathic POI affects 1.1% of all women and almost half of the women with premature menopause. Autoimmunity explains 4.5% of these cases judged by positive steroidogenic autoantibodies. Bioscientifica Ltd 2022-04-22 /pmc/articles/PMC9175594/ /pubmed/35521804 http://dx.doi.org/10.1530/EC-22-0024 Text en © The authors https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Research Vogt, Elinor Chelsom Real, Francisco Gómez Husebye, Eystein Sverre Björnsdottir, Sigridur Benediktsdottir, Bryndis Bertelsen, Randi Jacobsen Demoly, Pascal Franklin, Karl Anders de Aja Gallastegui, Leire Sainz González, Francisco Javier Callejas Heinrich, Joachim Holm, Mathias Jogi, Nils Oscar Leynaert, Benedicte Lindberg, Eva Malinovschi, Andrei Martínez-Moratalla, Jesús Mayoral, Raúl Godoy Oudin, Anna Pereira-Vega, Antonio Semjen, Chantal Raherison Schlünssen, Vivi Triebner, Kai Øksnes, Marianne Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
title | Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
title_full | Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
title_fullStr | Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
title_full_unstemmed | Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
title_short | Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
title_sort | premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175594/ https://www.ncbi.nlm.nih.gov/pubmed/35521804 http://dx.doi.org/10.1530/EC-22-0024 |
work_keys_str_mv | AT vogtelinorchelsom prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT realfranciscogomez prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT husebyeeysteinsverre prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT bjornsdottirsigridur prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT benediktsdottirbryndis prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT bertelsenrandijacobsen prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT demolypascal prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT franklinkarlanders prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT deajagallasteguileiresainz prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT gonzalezfranciscojaviercallejas prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT heinrichjoachim prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT holmmathias prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT joginilsoscar prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT leynaertbenedicte prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT lindbergeva prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT malinovschiandrei prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT martinezmoratallajesus prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT mayoralraulgodoy prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT oudinanna prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT pereiravegaantonio prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT semjenchantalraherison prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT schlunssenvivi prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT triebnerkai prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts AT øksnesmarianne prematuremenopauseandautoimmuneprimaryovarianinsufficiencyintwointernationalmulticentercohorts |